For decades, one of the greatest challenges to treating neurological disorders like attention-deficit/hyperactivity disorder ...

In the historical context, psychedelics reveal a spectrum of applications, ranging from spiritual and recreational use to ...

First severe mpox clade I case identified in NYC resident who traveled abroad. Health officials say local transmission risk remains low for the community.

Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical data and approvals approach.

Frontotemporal dementia (FTD), in particular, may be at play, and identifying ways to slow down its progression can help. In ...

Praxis Precision Medicines develops clinical-stage therapies for neurological disorders, targeting major unmet needs in CNS therapeutics.

A new UCLA Health study suggests that long-term exposure to the pesticide chlorpyrifos may dramatically raise the risk of Parkinson’s disease. Researchers found that people living in areas with ...

Authorities also plan to begin admitting international students to the permanent campus from the next academic session.

The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b ...

Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and ...

Anti-vaccine activists rally supporters to try to keep the momentum going on changing federal vaccine policies. This comes ...

Parkinson's disease is the fastest growing neurological disorder, with more than 10 million cases worldwide. Up to 150,000 ...